Cardiac disease in pregnancy medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Cardiac disease in pregnancy}} {{CMG}}; {{AOEIC}} {{CZ}} ==Antibiotic Prophylaxis== The official [http://www.americanheart.org American Heart Association] (AHA) recommendat...")
 
(#REDIRECT)
 
Line 1: Line 1:
{{Cardiac disease in pregnancy}}
#REDIRECT [[Cardiac disease in pregnancy and valvular heart disease#Antibiotic Prophylaxis]]
{{CMG}}; {{AOEIC}} {{CZ}}
 
==Antibiotic Prophylaxis==
The official [http://www.americanheart.org American Heart Association] (AHA) recommendation is that antibody prophylaxis is not necessary for an uncomplicated delivery except among patients with a [[prosthetic heart valve]] or surgically constructed systemic to pulmonary shunt. However, because of the difficulties in predicting complicated deliveries and the potential devastating consequences of [[endocarditis]], antibiotic prophylaxis for vaginal delivery in all patients with [[congenital heart disease]] expect those with an isolated secundum type [[atrial septal defect]] and those six months or more after repair of septal defects or surgical ligation division of a patent duct is [[patent duct arteriosus|arteriosus]], seems reasonable. At the time of delivery it is recommended that all women with [[valvular heart disease]] receive [[antibiotics]], usually [[penicillin]] and [[gentamycin]]. For those with a [[pencillin allergy]], [[vancomycin]] is used.
 
==References==
{{Reflist|2}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Electrophysiology]]
[[Category:Emergency medicine]]

Latest revision as of 12:55, 22 April 2012